KB
The company develops companion diagnostic and therapeutic devices that utilize immunologic testing for the early diagnosis of bullous, vascular, connective tissue, and inherited skin diseases. By providing proprietary diagnostic services, they enable medical professionals to implement effective therapies based on accurate and timely diagnoses.
Updated 3 months ago
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops companion diagnostic and therapeutic devices that utilize immunologic testing for the early diagnosis of bullous, vascular, connective tissue, and inherited skin diseases. By providing proprietary diagnostic services, they enable medical professionals to implement effective therapies based on accurate and timely diagnoses.